外阴阴道念珠菌病患者菌群调查及其ERG5基因突变研究
DOI:
作者:
作者单位:

无锡市妇幼保健院检验科

作者简介:

通讯作者:

中图分类号:

基金项目:


Investigation of flora and mutation of ERG5 gene in vulvovaginal candidiasis Jin Lei,Weifeng Shi
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:了解本地区外阴阴道念珠菌病(VVC)的发生率以及感染的主要念珠菌种类,探讨VVC患者临床分离的白念珠菌对常用抗真菌药物的敏感性。PCR扩增白念珠菌的ERG5基因并测序分析,探讨白念珠菌ERG5基因突变是否与其耐药性有关。方法:采集2018年6月-12月妇产科门诊就诊患者的阴道分泌物,涂片镜检、CHROMagar念珠菌显色培养基培养获得285株念珠菌,再通过真菌快速培养鉴定/药敏试验获得156株白念珠菌及其体外药敏试验结果,并且对这156株白色念珠菌再次进行质谱鉴定。最后采用PCR技术扩增白念珠菌ERG5基因并测序分析其突变位点。结果: 初次检出的285株真菌中,白念菌株156株(54.7%)、光滑念珠菌64株(22.5%)、热带念珠菌47株(16.5%)、克柔念珠菌12株(4.2%)和其他真菌6株(2.1%)。MALDI-TOF MS对156株初筛的白念珠菌进行再次补充鉴定,结果显示有1株菌无法可靠鉴定出结果(质谱评分低于1.700分),其余均为白色念珠菌。白念珠菌体外药敏试验显示,155株白念珠菌均对5-氟尿嘧啶(5-FC)敏感,对两性霉素(AMB)、制霉菌素(NYS)敏感性达99.3%和98.7%,对酮康唑(KET)、氟康唑(FIU)、伊曲康唑(ITR)、伏立康唑(VOR)、克霉唑(CLO)、米康唑(MIC)、益康唑(ECO)耐药率分别为43.59%、62.82%、61.54%、50.64%、50.64%、51.92%和51.28%。挑选7株白色念株菌PCR扩增并测序分析,在同一位点检出2个ERG5基因突变,其中一个为同义突变(G528A),另一个为错义突变(G528C)。结论:(1)本院VVC患者白念珠菌的构成比呈下降趋势,而非白念逐渐上升。(2)当传统表型鉴定难以确定时,可通过质谱技术补充鉴定。(3)白念珠菌对5-FC、AMB、NYS高度敏感,而对唑类药物耐药性增高,并存在交叉耐药和多药耐药现象。(4)白念珠菌ERG5基因528位点突变可能与唑类药物的耐药性有关。

    Abstract:

    Objective: To understand the incidence of candida vaginitis and the main types of Candida in this area,and explore the common antifungal antimicrobial sensitivity of C.albicans isolated from clinical. The ERG5 genes of C.albicans was amplified by PCR and sequencing and to investigate whether the mutation of ERG5 genes of C.albicans was associated with its drug resistance.Methods: During Jun to Dec 2018,vaginal secretions from gynecologic and obstetric outpatients were collected, and 285 strains of Candida were obtained by smear microscopy and CHROMagar chromogenic medium culture.Additionally, the identification and susceptibility tests of 156 C.albicans were detected by rapid fungal culture and drug sensitivity tests,as well as mass spectrometry. The ERG5 genes of C. albicans was amplified by PCR and sequencing for the analysis of mutation sites.Results: Of 285 fungi detected for the first time, C.albicans C.smooth, C.tropicalis, C.krusei and other fungi accounted for 156 (54.7%), 64(22.5%), 47(16.5%), 12(4.2%),and 6(2.1%),respectively. 156 strains of C.albicans were further identified by MALDI-TOF MS, indicating that One strain could mot be reliably identified(Score below 1.700) and the rest were C.albicans . strain Antimicrobial susceptibility tests in vitro showed that 155 strains of C.albicans were sensitive to 5-fluorouracil (5-FC), and the sensitivity to amphotericin (AMB) and nystatin (NYS) was 99.3% and 98.7%,respectively. However, the resistance rates of 155 strains against ketoconazole(KET),fluconazole(FIU),itraconazole(ITR),voriconazole(VOR),clotrimazole(CLO),miconazole(MIC), Econazole (ECO) were 43.59%, 62.82%, 61.54%, 50.64%, 50.64%, 51.92% and 51.28%, respectively. The ERG5 genes in 7 strains of C.albicans were chosen to be amplified by PCR and sequencing. Two mutation loci of ERG5 were found at the same site, one of which was synonymous mutation (G528A) and the other was missense mutation (G528C).Conclusions: (1)The proportion of C.albicans in VVC patients showed a downward trend, while non C.albicans gradually increased in our hospital.(2)When the traditional phenotypic identification is difficult to determine, it can be supplemented by mass spectrometry technique. (3)C.albicans is highly sensitive to 5-FC, AMB and NYS, but the resistance to azole drugs increased. There are cross-resistance and multi-drug resistance among C.albicans.(4)The mutation of ERG5 gene at 528 locus in C.albicans may be related to azole resistance.

    参考文献
    相似文献
    引证文献
引用本文

金蕾.外阴阴道念珠菌病患者菌群调查及其ERG5基因突变研究[J].临床检验杂志,2021,(4):307-309

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-11-16
  • 最后修改日期:2021-05-19
  • 录用日期:2021-04-25
  • 在线发布日期: 2021-08-08
  • 出版日期: 2021-04-28
您是第位访问者  苏ICP备12051282号-1
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司